SOHEIL SALIMI: Open Payments
NPI 1326612219 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 27 payments from 10 companies in 2025. Trend: 2023 $186 · 2024 $445 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $185 |
| Janssen Biotech, Inc. | 3 | $88 |
| Novo Nordisk Inc | 2 | $42 |
| GENZYME CORPORATION | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Boston Scientific Corporation | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $15 |
Products named: RINVOQ, TREMFYA, LINZESS, DUPIXENT, Wegovy, CREON, IQIRVO, Axonics.
Industry payments across FL — which companies pay providers there.
